Alkem Labs signs pact to market Stempeutics’ stem cell therapy for osteoarthritis – Moneycontrol.com
Moneycontrol.com |
Alkem Labs signs pact to market Stempeutics' stem cell therapy for osteoarthritis
Moneycontrol.com The potential for stem cell therapy market in India is around USD 540 million and expected to grow rapidly. “While the opportunity is good, it is important that the stem cell therapy is affordable for the common man. Therefore our focus is on to … Stempeutics & Alkem signed a co-development agreement for its stemcell therapy product Stempeucel |
